<< Back
Spectrum Pharmaceuticals Chosen as One of the 'Best Companies To Work For' by OC METRO Magazine

IRVINE, Calif., June 10, 2005 /PRNewswire-FirstCall via COMTEX/ -- Spectrum Pharmaceuticals, Inc. (Nasdaq: SPPI) today announced today that they have been chosen as one of Orange County's Best Companies to Work for by OC METRO Magazine, a business lifestyle magazine that distributes news and information for readers in Orange County, California. The full article is carried in the June 9, 2005 edition of the magazine.

"We are so excited to be named as one of Orange County's best companies to work for," stated Rajesh C. Shrotriya, M.D., Chairman, Chief Executive Officer and President. "In today's competitive work environment, it is so important to not only have a strong strategic vision for the future growth of the company, but to have a dedicated and motivated employee workforce that cares about what they are building together. We encourage a hardworking, yet fun work environment at Spectrum and I believe that our success in the past few years is a direct result of that work ethic."

About Spectrum Pharmaceuticals

Spectrum Pharmaceuticals is a specialty pharmaceutical company engaged in the business of acquiring, developing and commercializing prescription drug products for the treatment of cancer and other unmet medical needs. By leveraging its operational flexibility and regulatory proficiency, and using the extensive research and development capabilities of its strategic alliance partners, Spectrum has built a diversified portfolio of proprietary and generic drug products in various stages of development and regulatory approval. For more information, please visit our website at www.spectrumpharm.com.

Forward-looking statements

This press release may contain forward-looking statements regarding future events and the future performance of Spectrum Pharmaceuticals that involve risks and uncertainties that could cause actual results to differ materially. These statements include but are not limited to statements that relate to our business and its future, the Company's strong strategic vision, a dedicated and motivated employee workforce, the Company's operational flexibility and regulatory proficiency, the extensive research and development capabilities of the Company's strategic alliance partners, and any statements that relate to the intent, belief, plans or expectations of Spectrum or its management, or that are not a statement of historical fact. Risks that could cause actual results to differ include the possibility that our existing and new drug candidates, may not prove safe or effective, the possibility that our existing and new drug candidates may not receive approval from the FDA, and other regulatory agencies in a timely manner or at all, the possibility that our existing and new drug candidates, if approved, may not be more effective, safer or more cost efficient than competing drugs, the possibility that price and other competitive pressures may make the marketing and sale of our generic drugs not commercially feasible, the possibility that our efforts to acquire or in-license and develop additional drug candidates may fail, our lack of revenues, our limited experience in establishing strategic alliances, our limited marketing experience, our limited experience with the generic drug industry, our dependence on third parties for clinical trials, manufacturing, distribution and quality control and other risks that are described in further detail in the Company's reports filed with the Securities and Exchange Commission.

CONTACT:
     Rajesh C. Shrotriya, M.D.
     CEO and President
     +1-949-743-9295

     Laurie Little
     Sr. Director, Investor Relations
     +1-949-743-9216

SOURCE Spectrum Pharmaceuticals, Inc.

Rajesh C. Shrotriya, M.D., CEO and President, +1-949-743-9295, or Laurie Little, Sr.
Director, Investor Relations, +1-949-743-9216, both of Spectrum Pharmaceuticals
http://www.prnewswire.com
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding Spectrum Pharmaceuticals Inc's business which are not historical facts are "forward-looking statements" that involve risks and uncertainties. For a discussion of such risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see "Risk Factors" in the Company's Annual Report or Form 10-K for the most recently ended fiscal year.